We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFWM
2201
DELISTED
First Foundation Inc
FFWM
$132K ﹤0.01%
5,886
+2,098
+55% +$50.4K
LTC
2202
LTC Properties
LTC
$2.15B
$132K ﹤0.01%
3,415
-2,637
-44% -$107K
IBCP icon
2203
Independent Bank Corp
IBCP
$844M
$131K ﹤0.01%
6,003
+3,974
+196% +$91.7K
MARA icon
2204
Marathon Digital Holdings
MARA
$3.9B
$131K ﹤0.01%
4,171
+3,755
+903% +$119K
MTH icon
2205
Meritage Homes
MTH
$4.86B
$131K ﹤0.01%
2,778
-21,322
-88% -$1.08M
NEU icon
2206
NewMarket
NEU
$8.18B
$131K ﹤0.01%
406
-5
-1% -$1.75K
OCFC icon
2207
OceanFirst Financial
OCFC
$1.91B
$131K ﹤0.01%
6,272
+1,888
+43% +$42.3K
OPCH icon
2208
Option Care Health
OPCH
$3.56B
$131K ﹤0.01%
5,989
-3,003
-33% -$57.9K
NBIS
2209
Nebius Group N.V.
NBIS
$47.7B
$131K ﹤0.01%
1,852
-8,301
-82% -$545K
CLLS
2210
Cellectis
CLLS
$285M
$130K ﹤0.01%
8,409
-324
-4% -$5.45K
EWA icon
2211
iShares MSCI Australia ETF
EWA
$1.48B
$130K ﹤0.01%
4,994
-9,193
-65% -$242K
IDCC icon
2212
InterDigital
IDCC
$8.89B
$130K ﹤0.01%
1,772
-3,583
-67% -$265K
MC icon
2213
Moelis & Co
MC
$4.94B
$130K ﹤0.01%
2,279
-2,976
-57% -$162K
PHAT icon
2214
Phathom Pharmaceuticals
PHAT
$692M
$130K ﹤0.01%
3,833
+2,517
+191% +$90.1K
PNR icon
2215
Pentair
PNR
$11B
$130K ﹤0.01%
1,919
-16,545
-90% -$1.09M
CVBF icon
2216
CVB Financial
CVBF
$3.99B
$129K ﹤0.01%
6,257
-6,474
-51% -$141K
HOOK
2217
DELISTED
HOOKIPA Pharma
HOOK
$129K ﹤0.01%
1,409
+1,302
+1,217% +$174K
IJT icon
2218
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.41B
$129K ﹤0.01%
970
-5,318
-85% -$692K
TIMB icon
2219
TIM SA
TIMB
$8.8B
$129K ﹤0.01%
+11,119
New +$129K
TSC
2220
DELISTED
TriState Capital Holdings, Inc.
TSC
$129K ﹤0.01%
6,331
+4,078
+181% +$93K
EWS icon
2221
iShares MSCI Singapore ETF
EWS
$1.15B
$128K ﹤0.01%
5,495
+3,002
+120% +$70.9K
HMC icon
2222
Honda
HMC
$41.3B
$128K ﹤0.01%
3,969
+2,307
+139% +$71.7K
RCUS icon
2223
Arcus Biosciences
RCUS
$3.64B
$128K ﹤0.01%
4,629
-46
-1% -$1.31K
SHOO icon
2224
Steven Madden
SHOO
$3.55B
$128K ﹤0.01%
2,927
-10,308
-78% -$425K
JBTM
2225
JBT Marel
JBTM
$6.39B
$128K ﹤0.01%
894
-4,305
-83% -$601K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.